/
KNTPF
$0.34+$0.06 (+22.10%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.22 – $0.57
36% from low
Exchange
OTC Link
OS
Price (6 mo)
Loading chart…
Change$-9.66
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $698 | $0 | $0 | $34.2M | $0 | $0 | $5.0M | $31.8M |
| Cost of revenue | $689 | $0 | $942.1K | $0 | $2.7M | $42.2M | $9.7M | $56.4M |
| Gross profit | $9 | $0 | −$942.1K | $34.2M | −$2.7M | −$42.2M | −$4.7M | −$24.5M |
| Gross margin | 1.3% | — | — | 100.0% | — | — | -94.6% | -77.0% |
| R&D | $93.2K | $214.0M | $328.8M | $767.9K | $828.0M | $938.9M | $78.1M | $61.1M |
| Operating income | −$109.6K | −$218.2M | −$504.9M | −$839.6M | −$944.5M | −$152.4M | −$144.6M | −$197.4M |
| EBITDA | −$108.4M | −$216.4M | −$396.3M | −$828.0M | −$956.4M | −$1.06B | −$128.4M | −$165.0M |
| Net income | −$108.5K | −$232.6M | −$508.3M | −$842.1M | −$954.4M | −$1.06B | −$155.3M | −$194.9M |
| Net margin | -15542.1% | — | — | -2460.0% | — | — | -3105.8% | -612.3% |
| EPS (diluted) | -0.50 | -0.97 | -1.64 | -2.36 | -2.53 | -2.47 | -0.36 | -0.43 |
Annual figures · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$0.16
Price
$0.34
Implied downside
-53%
Peer comparison
KINTOR PHARMACEUTICAL
KINTOR PHARMACEUTICAL
Held by traders on TradeandTell
No one on the platform currently holds KNTPF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in KNTPF as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded KNTPF yet.